ArticleAnnals of surgical oncology2026
Lymph Node Metastasis Frequency and Development of Predictive Model in T1b Gastric Cancer: A Single-Center Study.
Article in Annals of surgical oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Distinguishing second primary tumors from local recurrence in type 1 gastric neuroendocrine tumors: a risk-stratified management strategy.Surgical endoscopy · 2026Article
- Association between primary tumor location and lymph node metastatic patterns in gastric cancer: A single-center retrospective study.Medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
backgroundThe optimal management of T1b gastric cancer (GC) remains controversial, largely due to the risk of lymph node metastasis (LNM). This study aimed to clarify the anatomical distribution of LNM and develop a predictive nomogram for patients with T1b GC. PATIENTS AND
methodsClinical and pathological data from 1041 patients with pathologically confirmed T1b GC who underwent D2 gastrectomy at a single high-volume center in China were retrospectively analyzed. The frequency and distribution of LNM, including skip metastases, were assessed. Predictive factors identified by logistic regression were incorporated into a nomogram, which was evaluated using receiver operating characteristic (ROC) curves, decision curve analysis (DCA), and calibration plots.
resultsThe overall incidence of LNM was 28.34%, with first- and second-tier rates of 25.4% and 10.3%, respectively. LNM occurred across almost all nodal stations without a consistent anatomical pattern. Lymph node skip metastasis was detected in 2.98% of patients, with no reliable predictors. Importantly, no LNM was observed in well-differentiated tumors ≤ 3 cm, and in moderately to well-differentiated tumors of this size, metastases were confined to first-tier nodes. Multivariable analysis identified female, younger age, larger tumor size, horizontal location, poor differentiation, signet ring cell component, and lymphovascular invasion as independent predictors. The nomogram incorporating these factors demonstrated good discrimination (AUC 0.83; 95% CI 0.80-0.86) and favorable calibration and clinical utility.
conclusionsLNM in T1b GC shows a heterogeneous distribution and cannot be predicted by anatomical site alone. Sentinel lymph node biopsy with limited resection may be feasible for carefully selected patients with ≤ 3 cm, moderately to well-differentiated tumors, while D2 gastrectomy remains standard for others. The proposed nomogram may facilitate individualized surgical decision-making but requires external validation.
Indexed as
Identifiers
41186644What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.